Avita Medical, Inc. (RCEL) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Aveda Medical Second Quarter 2025 earnings conference call. At this time, all participants are in the listen only mode. After the speaker's presentation, we'll open up for questions. To ask a question during the session, you will need to press star 101 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 101 again. Please be advised that today's call is being recorded. Oh, and I'll hand it over to your first speaker today, Ben Atkins, Vice President Investor Relations. Please go ahead. Thank you, operator. Welcome to Aveda Medical's Second Quarter 2025 earnings call. Before we begin, I would like to introduce myself. My name is Ben Atkins and I started at Aveda in July, leaving investor relations and corporate communications. With many years of working in life sciences, I am thrilled to be part of Aveda and this team. And I look forward to working with our investor community. Joining me on today's call are Jim Corbett, Chief Executive Officer, and David O'Toole, Chief Financial Officer. Today's earnings release and presentation are available on our website, .avetamedical.com, under the investor relations section. Before we begin, I would like to remind you that this call includes forward-looking statements within the meaning of the Private Security and Litigation Reform Act of 1995. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results to differ materially from any expectations expressed or implied by the forward-looking statements. Please review our most recent filings with the SEC for comprehensive descriptions of the risk factors. Any forward-look...